Antibiotic Therapy for Ambulatory Patients With Community-Acquired Pneumonia in an Emergency Department Setting

Abstract
COMMUNITY-ACQUIRED pneumonia (CAP) is a common disease in North America with significant morbidity and mortality.1-3 Since the etiologic agent remains unidentified in up to 50% of cases1-3 and a delay of more than 8 hours in antimicrobial therapy is associated with increased mortality,4 prompt empiric therapy for CAP is essential.

This publication has 12 references indexed in Scilit: